The company develops, manufactures and sells biotechnologically produced cellulose, in particular for application on and in the human body.
Die Entwicklung, die Herstellung und der Vertrieb von biotechnologisch gewonnener Cellulose insbesondere zur Anwendung am und im menschlichen Körper.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Essen Local Court, HRB 32862 (as of 2 November 2026)
| Name | Type | City |
|---|---|---|
| Dana Kralisch | Geschäftsführer(in) | Jena |
Source: German Commercial Register (Handelsregister) Essen Local Court, HRB 32862 (as of 2 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 21.10.2021 | Company Name Registered | JeNaCell GmbH |
| 21.10.2021 | Registered Seat | Essen |
| 21.10.2021 | Business Address Registered | Göschwitzer Straße 22, 07745 Jena |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 21.10.2021 | Share Capital Set | — | 164.059 € |
Source: German Commercial Register (Handelsregister) Essen Local Court, HRB 32862 (as of 2 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €1,271,877 | €0 | €7,364,875 | — |
| 2023 | €1,306,875 | €0 | €5,689,663 | — |
| 2022 | €879,308 | €0 | €4,350,910 | — |
| 2021 | €945,809 | -€1,127,094 | €3,305,059 | — |
| 2020 | small company1 | — | €4,095,744 | — |
| 2019 | — | — | €2,442,861 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Sign in to download data
Source: German Commercial Register (Handelsregister) Essen Local Court, HRB 32862 (as of 2 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €2,051,779 | 65.9% |
| Material Costs | €472,651 | 15.2% |
| Depreciation | €473,299 | 15.2% |
| Interest & Similar | €118,097 | 3.8% |
